Evidence map›Paper›PMID 28213860›Full record

ReviewWorld journal of urology2017

Epidemiology of stone disease across the world.

Igor Sorokin, Charalampos Mamoulakis, Katsuhito Miyazawa, Allen Rodgers, Jamsheer Talati, Yair Lotan

3 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 574 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
574citing papers in PubMed, 12 pooled it
35.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04556201 nacompletednot on this mapstarted 2020, after this paper: background citation

A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones

TypeinterventionalSponsorOlympus Corporation of the AmericasRan2020 to 2023Enrolled450ConditionsKidney Stone, Ureteral StoneArmsSOLTIVE™ Premium SuperPulsed Laser Fiber System
NCT05218057 nacompletednot on this mapstarted 2022, after this paper: background citation

TFL vs Ho:YAG - A Prospective Study to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy

TypeinterventionalSponsorChinese University of Hong KongRan2022 to 2023Enrolled46ConditionsUreteric StoneArmsUreteroscopic lithotripsy
NCT06660914 narecruitingnot on this mapstarted 2024, after this paper: background citation

A Randomized Controlled Trial Comparing Robotic Flexible Ureteroscopy With Standard Flexible Ureteroscopy for Treatment of Renal Stones - A Pilot Study

TypeinterventionalSponsorChinese University of Hong KongRan2024 to 2026Enrolled30ConditionsRenal StoneArmsFlexible Ureteroscopy
3 · Its place in the literature

Who cites it

574 citing papers in PubMed, 12 syntheses or guidelines pooled it, 1,135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

514 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Igor SorokinDepartment of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
Charalampos MamoulakisDepartment of Urology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece.
Katsuhito MiyazawaDepartment of Urology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Allen RodgersDepartment of Chemistry, University of Cape Town, Cape Town, South Africa.
Jamsheer TalatiSection of Urology, Aga Khan University, Karachi, Pakistan.
Yair LotanDepartment of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA. Yair.Lotan@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USAga Khan University · PKKanazawa Medical University · JPUniversity of Cape Town · ZAUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrolithiasis is a highly prevalent disease worldwide with rates ranging from 7 to 13% in North America, 5-9% in Europe, and 1-5% in Asia. Due to high rates of new and recurrent stones, management of stones is expensive and the disease has a high level of acute and chronic morbidity. The goal of this study is to review the epidemiology of stone disease in order to improve patient care. A review of the literature was conducted through a search on Pubmed

Indexed as

Global HealthAge FactorsDiabetes MellitusHumansIncidenceNephrolithiasisObesityPrevalenceRisk FactorsSex FactorsUrolithiasisEpidemiologyKidney stonesNephrolithiasisRenal calculiUrolithiasis

Identifiers

PMID28213860
OpenAlexW2588771666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.